Wednesday, August 20, 2014

Clarithromycin Linked to Increased Cardiac Death Risk

(HealthDay News) -- There is a significantly increased risk of cardiac death associated with clarithromycin use, according to a study published online August 19 in BMJ.

Henrik Svanstr√∂m, from the Statens Serum Institut in Copenhagen, Denmark, and colleagues assessed the risk of cardiac death associated with use of clarithromycin and roxithromycin compared with penicillin V in Danish adults (aged 40–74 years). Participants had received seven-day treatment courses with clarithromycin (160,297 adults), roxithromycin (588,988 adults), and penicillin V (4,355,309 adults).

Here is the source article:

No comments:

Post a Comment

Please be constructive in your comments.